NBC Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.96K Buy
+12
New +$3.05K ﹤0.01% 2215
2026
Q2
– Sell
-10
Closed -$3.31K – 2424
2026
Q1
$3.31K Buy
10
+2
+25% +$681 ﹤0.01% 2215
2025
Q4
$3.18K Sell
8
-4
-33% -$1.77K ﹤0.01% 2323
2025
Q3
$5.47K Hold
12
– – ﹤0.01% 2178
2025
Q2
$3K Buy
+12
New +$3.32K ﹤0.01% 2195
2024
Q1
– Sell
-16
Closed -$3K – 2180
2023
Q4
$3K Hold
16
– – ﹤0.01% 1935
2023
Q3
$2K Buy
+16
New +$3.05K ﹤0.01% 1983

Other funds holding ALNY

NBC Securities's ALNY Position: Q3 2026 in Review

NBC Securities opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 12 shares worth $2.96K. The stake represents ﹤0.01% of the portfolio and ranks #2215 among its holdings. This is a return to the name: NBC Securities previously reported a position in ALNY as recently as Q1 2026.

NBC Securities first reported a position in ALNY in Q3 2023 and has held it in 7 quarters since. The position peaked at $5.47K in Q3 2025. 720 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • NBC Securities held 12 shares of Alnylam Pharmaceuticals worth $2.96K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new NBC Securities position in Q3 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #2215 holding.
  • NBC Securities first reported a position in Alnylam Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
  • NBC Securities's Alnylam Pharmaceuticals position peaked at $5.47K in Q3 2025.
  • 720 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.